| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aim Immunotech Inc. (AIM) has 2 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. AIM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 63.9K | $32.9K | - | |
| Dir | 28.4K | $14.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Equels Thomas K | CEO &President | Buy | 107 | $7.70 | $823.58 | +0.3% | -61.2% | - | |
| Jun 12, 2025 | Equels Thomas K | CEO &President | Buy | 103 | $8.70 | $896.10 | +0.3% | -69.1% | - | |
| Apr 11, 2025 | Kellner Ted D | Director | Buy | 1,968,504 | $0.03 | $50,000.00 | +196,850% | +212.0% | -82.0% | |
| Apr 11, 2025 | Equels Thomas K | CEO &President | Buy | 1,968,504 | $0.03 | $50,000.00 | +103.7% | +212.0% | -82.0% | |
| Apr 11, 2025 | Mitchell William M | Director | Buy | 196,851 | $0.03 | $5,000.02 | +60.6% | +212.0% | -82.0% | |
| Apr 4, 2025 | Equels Thomas K | CEO &President | Buy | 41,000 | $0.06 | $2,583.00 | +2.2% | -1.7% | -93.2% | |
| Apr 4, 2025 | Rodino Peter W III | COO, Secretary, Gen. Counsel | Buy | 500 | $0.09 | $43.50 | +0.1% | -1.7% | -93.2% | |
| Mar 5, 2025 | Equels Thomas K | CEO &President | Buy | 50,000 | $0.13 | $6,730.00 | +2.8% | -38.5% | -94.9% | |
| Mar 4, 2025 | Equels Thomas K | CEO &President | Buy | 44,000 | $0.12 | $5,060.00 | +2.5% | -41.7% | -94.1% | |
| Mar 4, 2025 | Equels Thomas K | CEO &President | Buy | 83,334 | $0.12 | $10,000.08 | +5.0% | -41.7% | -94.1% |